Concentrix Co. (NASDAQ:CNXC) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its position in shares of Concentrix Co. (NASDAQ:CNXCFree Report) by 89.1% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 2,486 shares of the company’s stock after selling 20,344 shares during the period. SG Americas Securities LLC’s holdings in Concentrix were worth $127,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CNXC. Impactive Capital LP increased its position in Concentrix by 13.0% during the 1st quarter. Impactive Capital LP now owns 3,846,370 shares of the company’s stock worth $254,707,000 after purchasing an additional 443,045 shares in the last quarter. Capital International Investors raised its stake in shares of Concentrix by 0.3% in the 1st quarter. Capital International Investors now owns 2,525,762 shares of the company’s stock valued at $167,256,000 after acquiring an additional 7,333 shares during the period. Pzena Investment Management LLC raised its stake in shares of Concentrix by 46.6% in the 2nd quarter. Pzena Investment Management LLC now owns 1,484,907 shares of the company’s stock valued at $93,965,000 after acquiring an additional 471,699 shares during the period. 1832 Asset Management L.P. purchased a new stake in Concentrix during the 2nd quarter worth $62,738,000. Finally, AQR Capital Management LLC increased its holdings in Concentrix by 74.4% in the 2nd quarter. AQR Capital Management LLC now owns 813,864 shares of the company’s stock valued at $51,160,000 after purchasing an additional 347,230 shares in the last quarter. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Concentrix Price Performance

CNXC stock opened at $44.52 on Friday. The stock’s 50 day moving average is $60.41 and its two-hundred day moving average is $61.76. Concentrix Co. has a 52-week low of $44.18 and a 52-week high of $106.10. The company has a market capitalization of $2.89 billion, a PE ratio of 14.45, a P/E/G ratio of 0.62 and a beta of 0.58. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.18.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its quarterly earnings results on Wednesday, September 25th. The company reported $2.87 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.93 by ($0.06). Concentrix had a return on equity of 16.57% and a net margin of 2.18%. The company had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter last year, the firm posted $2.54 EPS. The firm’s quarterly revenue was up 46.2% on a year-over-year basis. Analysts predict that Concentrix Co. will post 10.18 earnings per share for the current fiscal year.

Concentrix Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 5th. Stockholders of record on Friday, October 25th will be paid a $0.333 dividend. This represents a $1.33 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date is Friday, October 25th. This is a positive change from Concentrix’s previous quarterly dividend of $0.30. Concentrix’s dividend payout ratio is 39.29%.

Insider Buying and Selling

In other Concentrix news, CEO Christopher A. Caldwell sold 9,823 shares of the company’s stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $52.70, for a total transaction of $517,672.10. Following the sale, the chief executive officer now owns 241,841 shares in the company, valued at $12,745,020.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Cormac J. Twomey sold 400 shares of Concentrix stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $74.63, for a total value of $29,852.00. Following the completion of the transaction, the executive vice president now directly owns 29,327 shares of the company’s stock, valued at approximately $2,188,674.01. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Christopher A. Caldwell sold 9,823 shares of the business’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $52.70, for a total transaction of $517,672.10. Following the sale, the chief executive officer now directly owns 241,841 shares of the company’s stock, valued at approximately $12,745,020.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 12,167 shares of company stock worth $653,747. Corporate insiders own 3.10% of the company’s stock.

Wall Street Analyst Weigh In

CNXC has been the topic of a number of recent research reports. Robert W. Baird began coverage on Concentrix in a research note on Thursday, October 3rd. They set an “outperform” rating and a $70.00 price objective on the stock. Baird R W raised Concentrix to a “strong-buy” rating in a research report on Thursday, October 3rd. Canaccord Genuity Group lowered their price objective on shares of Concentrix from $125.00 to $100.00 and set a “buy” rating for the company in a research report on Thursday, September 26th. Barrington Research reduced their target price on shares of Concentrix from $84.00 to $70.00 and set an “outperform” rating on the stock in a research report on Thursday, September 26th. Finally, Bank of America lowered their price target on shares of Concentrix from $85.00 to $70.00 and set a “neutral” rating for the company in a report on Thursday, September 26th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Concentrix has a consensus rating of “Buy” and a consensus target price of $79.00.

View Our Latest Research Report on Concentrix

Concentrix Profile

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Further Reading

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Co. (NASDAQ:CNXCFree Report).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.